GLP-1 Drugs Tied to Lower Addiction Risk In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths. By Kathryn Wighton May 27, 2026 5 min Conexiant Share Summary Listen Insight Report Quiz Poll Top Institutions